Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01036581 · ClinicalTrials.gov registry record · NA

Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

A NA study of Nicotine Dependence and Drug Abuse, sponsored by National Institute on Drug Abuse (NIDA).

Recruiting
Registry status
NA
Development phase
1,000
Enrollment target
1
Study location

NCT01036581 is a NA study of Nicotine Dependence and Drug Abuse that is actively recruiting participants, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 1,000 participants, above the 172-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (481% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01036581, a NA study of Nicotine Dependence and Drug Abuse, is actively recruiting participants, sponsored by National Institute on Drug Abuse (NIDA).

RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target
1
Study location

Study Summary

Background: \- Functional and structural magnetic resonance imaging (MRI) techniques have allowed researchers to map and study how the brain works when at rest and when engaged in specific tasks. MRI scans have provided more information about how drugs affect the brain, and about how drug addiction changes the brain and influences behavior, mood, and thinking processes. To better understand the underlying mechanism of drug addiction and to develop strategies for more effective treatment, researchers are interested in developing new MRI techniques to study the effects of addiction on the brain. Objectives: \- To develop new functional and structural MRI techniques, and to evaluate their potential use in brain imaging studies related to addiction. Eligibility: * Individuals between 18 and 80 years of age. * Participants may be smokers or nonsmokers, and may use drugs or not use drugs. Design: * During the initial screening, participants will complete questionnaires about family and personal history, drug use, and other information as required by the researchers. Participants who will be asked to complete tasks during the MRI scan will be shown how to perform these tasks before the scanning session. * Before each study session, participants may be asked to complete some or all of the following: questions about their drug use during the last week, a breathalyzer test, a urine drug-use assessment, a urine pregnancy test, or a measure of carbon monoxide. Participants will also provide blood samples before the start of the scan. * For each scanning session, participants will have an MRI scan that will last approximately 2 hours. * MRI scans may include specific tasks to be performed during the scan, or an experiment that studies the brain's response to carbon dioxide....

Interventions

  • DEVICE MagPro X100 Magnetic Stimulator
  • DEVICE Transcranial Rotating Magnetic Stimulator
  • DEVICE Magnetom Prisma Fit 3T Scanner

Study Locations (1)

Maryland

  • National Institute on Drug Abuse, Biomedical Research Center (BRC) - Baltimore

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2003-10-24
Est. Completion 2029-12-31
Phase NA

What the Registry Record Tells You About NCT01036581

The ClinicalTrials.gov registry entry for NCT01036581 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 172-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (481% higher). The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Nicotine Dependence appearing as the primary indexed condition, and to 3 interventions - of which MagPro X100 Magnetic Stimulator is the first listed.

NCT01036581 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT01036581 about?

NCT01036581 is a clinical study titled "Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging". Background: \- Functional and structural magnetic resonance imaging (MRI) techniques have allowed researchers to map and study how the brain works when at rest and when engaged in specific tasks. MRI scans have provided more information about how drugs affect the brain, and about how drug addiction...

What is the current status of trial NCT01036581?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2003-10-24. Estimated completion is 2029-12-31.

What conditions does trial NCT01036581 study?

This clinical trial studies the following conditions: Nicotine Dependence, Drug Abuse.

What interventions are being tested in trial NCT01036581?

The interventions under investigation include: MagPro X100 Magnetic Stimulator (DEVICE), Transcranial Rotating Magnetic Stimulator (DEVICE), Magnetom Prisma Fit 3T Scanner (DEVICE).

Who is sponsoring clinical trial NCT01036581?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01036581 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nicotine Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.